从五个受欢迎的人工智能聊天机器人对关于阿菲雷西斯最常被搜索的关键词的响应进行比较分析
Dilek Urtekin1, Neslişah Yaşar Kartal2
1Tekirdağ Namık Kemal University Hospital, Therapeutic Apheresis Center, Tekirdag, Turkey.
Journal of clinical apheresis
|December 26, 2025
概括
人工智能聊天机器人提供健康信息,但质量各不相同. DeepSeek v3 在表述查询的准确性方面表现出色,而 GPT-4o 提供了更好的可读性,尽管整体理解仍然是一个挑战.
科学领域:
- 医疗信息学 医疗信息学
- 医疗保健中的人工智能
- 卫生沟通健康沟通
背景情况:
- 人工智能聊天机器人越来越多地用于寻找健康信息.
- 关注人工智能产生的健康内容的准确性,质量和可读性.
- 在特定的医疗领域需要系统评估人工智能聊天机器人的性能.
研究的目的:
- 评估和比较来自五个领先的人工智能聊天机器人的质量,准确性和可读性,以回答有关度的查询.
- 识别聊天机器人,提供卓越的健康信息,在异位.
- 评估人工智能产生的信息的整体可理解性.
主要方法:
- 使用谷歌趋势识别了23个顶级的关键词.
- 提交了对五个AI聊天机器人的查询:GPT-4o,Gemini 2.5,Grok 3,DeepSeek v3 和 Copilot.
- 通过使用EQIP (质量),DISCERN (可靠性) 和Flesch-Kincaid指标 (可读性) 来评估答案.
主要成果:
- 聊天机器人的质量,准确性和可读性得分存在显著差异 (p=0.001).
- 深度搜索 v3 实现了最高的质量和准确性 (EQIP: 95.7%,DISCERN: 71.8).
- GPT-4o显示出最好的可读性 (FKRE: 43.1,FKGL: 9.1),而Copilot显示出最差的可读性.
结论:
- 人工智能聊天机器人在提供外表健康信息方面表现出相当大的变化.
- 像DeepSeek v3这样的新型号显示出对信息准确性的改进的承诺.
- 可读性仍然是一个问题,需要使用简单的语言进行沟通,以便更好地了解患者和提高健康素养.
更多相关视频
03:14Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
983
11:12Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of Biomacromolecular Drugs
Published on: March 9, 2013
35.4K
相关概念视频
Non-equilibrium in the Cell
5.3K
An important concept in studying metabolism and energy is that of chemical equilibrium. Most chemical reactions are reversible. They can proceed in both directions, releasing energy into their environment in one direction, and absorbing it from the environment in the other direction. The same is true for the chemical reactions involved in cell metabolism, such as the breaking down and building up of proteins into and from individual amino acids, respectively. Reactants within a closed system...
5.3K
Bone Marrow Sampling and Transplants
809
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
809
Hybridoma Technology
17.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.1K
